NCT00500578
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +6 more
- Locations
-
- U.T.M.D. Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Hematologic Neoplasms
Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.
1,046 public trials
269 recruiting studies
Hematologic Neoplasms trial results
Completed
Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
NCT00521859
- Conditions
- Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +12 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00421213
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +14 more
- Locations
-
- Miami, Florida, United States
- Chicago, Illinois, United States
- Bethesda, Maryland, United States
- Fargo, North Dakota, United States
NCT00592046
- Conditions
- Acute Leukemia, Anemia, Anemia, Refractory, +31 more
- Locations
-
- Houston, Texas, United States
NCT00056966
- Conditions
- Anemia, Anemia, Aplastic, Blood Protein Disorders, +35 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
- The Methodist Hospital Houston, Texas, United States
NCT00780598
- Conditions
- AML, Acute Myeloid Leukemia, Disease Attributes, +12 more
- Locations
-
- UCLA School of Medicine Los Angeles, California, United States
- Washington Cancer Institute Washington D.C., District of Columbia, United States
- M.D. Anderson Cancer Center Orlando Orlando, Florida, United States
- Emory University Clinic Atlanta, Georgia, United States
NCT00348959
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- St. James's Hospital Dublin, Ireland
NCT00389428
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- H. Lee Moffit Cancer Center & Research Institute at the University of S. Florida Tampa, Florida, United States
- North Shore University Hospital Manhasset, New York, United States
- New York Presbyterian Hospital Weill Medical College of Cornell University New York, United States
Completed
Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies
NCT00595686
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- Pfizer Investigational Site Augusta, Georgia, United States
- Pfizer Investigational Site Chapel Hill, North Carolina, United States
- Pfizer Investigational Site Pittsburgh, Pennsylvania, United States
- Pfizer Investigational Site Nashville, Tennessee, United States
NCT00741234
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancies, +7 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
- University of Wisconsin-Madison Madison, Wisconsin, United States
- National University Hospital Singapore
- National Cancer Center Singapore